South Korea Natural Killer (NK) Cell Therapeutics Market to 2032

Overview

The South Korea Natural Killer (NK) Cell Therapeutics Market is expected to reach a 195.92 USD Million by 2032 and is projected to grow at a CAGR of 115.45% from 2025 to 2032.

Revenue, 2024 (USD Million)
8.98
Forecast, 2032 (USD Million)
195.92
CAGR, 2024 - 2032
115.45%
Report Coverage
South Korea

South Korea Natural Killer (NK) Cell Therapeutics Market 2018-2032 USD Million

South Korea Natural Killer (NK) Cell Therapeutics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 8.98 USD Million
  • Projected Market Size (2032): 195.92 USD Million
  • CAGR (2025-2032): 115.45%

Key Findings of South Korea Natural Killer (NK) Cell Therapeutics Market

  • The South Korea Natural Killer (NK) Cell Therapeutics Market was valued at 195.92 USD Million in 2024.
  • The South Korea Natural Killer (NK) Cell Therapeutics Market is likely to grow at a CAGR of 115.45% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in Approaches Segment accounted for the largest share of the market with a revenue of 8.98 USD Million
  • The fastest growing segment Specialty Clinics in End User Segment grew Fastest with a CAGR of 125.56% during the forecast period from 2024 to 2032.

South Korea Natural Killer (NK) Cell Therapeutics Market Scope

South Korea Natural Killer (NK) Cell Therapeutics Market Segmentation & Scope
Application
  • Others
  • Gastrointestinal Diseases
  • Acute Infectious Diseases
  • Immunoproliferative Disorders
  • Cancer
Approaches
  • Bispecific Antibodies
  • Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
Therapeutics
  • NK Cell Directed Antibodies
  • NK Cell Therapies
Distribution Channel
  • Others
  • Direct Tender
  • Hospital Pharmacies
End User
  • Research & Academic Institutes
  • Specialty Clinics
  • Hospitals

South Korea Natural Killer (NK) Cell Therapeutics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2018
Unit Revenue in USD Million
Market Value in 2024 8.98 USD Million
Market Value in 2032 195.92 USD Million
CAGR (2025-2032) 115.45%
Historic Data 2016-2023
Market Segments Covered Application,Approaches,Therapeutics,Distribution Channel,End User

Regional Insights:

  • Leading Market (2024-2032): South Korea, leading in terms of revenue 8.98 USD Million in 2024
    • Key Country: South Korea, leading in terms of revenue with value of 8.98 USD Million in 2024.

Segments and Scope

  • South Korea Natural Killer (NK) Cell Therapeutics Market to 2032, By Application
    • Cancer is the largest segment in South Korea Natural Killer (NK) Cell Therapeutics Market to 2032 with a revenue of 8.51 USD Million in the year 2024.
    • Cancer is the Fastest growing segment in South Korea Natural Killer (NK) Cell Therapeutics Market to 2032 with a Growth rate of 119.46 % in forecast period 2025-2032.
  • South Korea Natural Killer (NK) Cell Therapeutics Market to 2032, By Approaches
    • Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) is the largest segment in South Korea Natural Killer (NK) Cell Therapeutics Market to 2032 with a revenue of 8.98 USD Million in the year 2024.
    • Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) is the Fastest growing segment in South Korea Natural Killer (NK) Cell Therapeutics Market to 2032 with a Growth rate of 115.45 % in forecast period 2025-2032.
  • South Korea Natural Killer (NK) Cell Therapeutics Market to 2032, By Therapeutics
    • NK Cell Therapies is the largest segment in South Korea Natural Killer (NK) Cell Therapeutics Market to 2032 with a revenue of 8.98 USD Million in the year 2024.
    • NK Cell Therapies is the Fastest growing segment in South Korea Natural Killer (NK) Cell Therapeutics Market to 2032 with a Growth rate of 110.01 % in forecast period 2025-2032.
  • South Korea Natural Killer (NK) Cell Therapeutics Market to 2032, By Distribution Channel
    • Hospital Pharmacies is the largest segment in South Korea Natural Killer (NK) Cell Therapeutics Market to 2032 with a revenue of 8.30 USD Million in the year 2024.
    • Hospital Pharmacies is the Fastest growing segment in South Korea Natural Killer (NK) Cell Therapeutics Market to 2032 with a Growth rate of 115.80 % in forecast period 2025-2032.
  • South Korea Natural Killer (NK) Cell Therapeutics Market to 2032, By End User
    • Hospitals is the largest segment in South Korea Natural Killer (NK) Cell Therapeutics Market to 2032 with a revenue of 8.17 USD Million in the year 2024.
    • Specialty Clinics is the Fastest growing segment in South Korea Natural Killer (NK) Cell Therapeutics Market to 2032 with a Growth rate of 114.86 % in forecast period 2025-2032.

South Korea Natural Killer (NK) Cell Therapeutics Market Company Share Analysis

 
South Korea Natural Killer (NK) Cell Therapeutics Market Company Share Analysis
South Korea Natural Killer (NK) Cell Therapeutics Market Company Share Analysis

South Korea Natural Killer (NK) Cell Therapeutics Market Geographical Sales Distribution, 2018-2032 USD Million

South Korea Natural Killer (NK) Cell Therapeutics Market Geographical Sales Distribution, 2018-2032 USD Million

South Korea Natural Killer (NK) Cell Therapeutics Market Company Profiling

South Korea Natural Killer (NK) Cell Therapeutics Market Company Profiling
Frequently Asked Questions
The South Korea Natural Killer (NK) Cell Therapeutics Market is segmented based on Segmentation Application,Approaches,Therapeutics,Distribution Channel,End User.
South Korea Natural Killer (NK) Cell Therapeutics Market was valued at USD 8.98(Revenue in USD Million) in 2018.
South Korea Natural Killer (NK) Cell Therapeutics Market is projected to grow at a CAGR of 115.45% during the forecast period of 2024 to 2032.
The Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) segment is expected to dominate the South Korea Natural Killer (NK) Cell Therapeutics Market, holding a largest market share of 8.98 USD Million in 2024

Coming Soon....

South Korea Natural Killer (NK) Cell Therapeutics Market Scope

South Korea Natural Killer (NK) Cell Therapeutics Market Segmentation & Scope
Application
  • Others
  • Gastrointestinal Diseases
  • Acute Infectious Diseases
  • Immunoproliferative Disorders
  • Cancer
Approaches
  • Bispecific Antibodies
  • Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
Therapeutics
  • NK Cell Directed Antibodies
  • NK Cell Therapies
Distribution Channel
  • Others
  • Direct Tender
  • Hospital Pharmacies
End User
  • Research & Academic Institutes
  • Specialty Clinics
  • Hospitals
Frequently Asked Questions
The South Korea Natural Killer (NK) Cell Therapeutics Market is segmented based on Segmentation Application,Approaches,Therapeutics,Distribution Channel,End User.
South Korea Natural Killer (NK) Cell Therapeutics Market was valued at USD 8.98(Revenue in USD Million) in 2018.
South Korea Natural Killer (NK) Cell Therapeutics Market is projected to grow at a CAGR of 115.45% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Natural Killer (NK) Cell Therapeutics Market for final year is USD 195.92 (USD Million).

South Korea Natural Killer (NK) Cell Therapeutics Market Company Profiling

South Korea Natural Killer (NK) Cell Therapeutics Market Company Profiling
Frequently Asked Questions
The South Korea Natural Killer (NK) Cell Therapeutics Market is segmented based on Segmentation Application,Approaches,Therapeutics,Distribution Channel,End User.
South Korea Natural Killer (NK) Cell Therapeutics Market was valued at USD 8.98(Revenue in USD Million) in 2018.
South Korea Natural Killer (NK) Cell Therapeutics Market is projected to grow at a CAGR of 115.45% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Natural Killer (NK) Cell Therapeutics Market for final year is USD 195.92 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.